Description: Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Home Page: www.formatherapeutics.com
FMTX Technical Analysis
300 North Beacon Street
Watertown,
MA
02472
United States
Phone:
617 679 1970
Officers
| Name | Title |
|---|---|
| Mr. Frank D. Lee | Pres & CEO |
| Mr. Todd E. Shegog | Sr. VP & CFO |
| Dr. John E. Bishop Ph.D. | Sr. VP & Chief Technology Officer |
| Dr. David N. Cook Ph.D. | Sr. VP & Chief Scientific Officer |
| Mr. Mario Vincent Corso C.F.A. | Head of Investor Relations |
| Dr. Jeannette Potts J.D., Ph.D. | Sr. VP, Gen. Counsel & Corp. Sec. |
| Ms. Xuandai Nguyen Ph.D. | VP of Commercial Strategy & Marketing |
| Ms. Linea Aspesi | Sr. VP & Chief HR Officer |
| Mr. Brian Lesser | Sr. VP of Commercial |
| Dr. Ifeyinwa Osunkwo M.D., M.P.H. | Sr. VP & Chief Patient Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.3105 |
| Price-to-Sales TTM: | 147.371 |
| IPO Date: | 2020-06-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 189 |